CN103044331A - Novel method for preparing Sildenafil intermediate 4-amino-1-methyl-3-n-propyl-pyrazole-5-formamide - Google Patents
Novel method for preparing Sildenafil intermediate 4-amino-1-methyl-3-n-propyl-pyrazole-5-formamide Download PDFInfo
- Publication number
- CN103044331A CN103044331A CN2013100117186A CN201310011718A CN103044331A CN 103044331 A CN103044331 A CN 103044331A CN 2013100117186 A CN2013100117186 A CN 2013100117186A CN 201310011718 A CN201310011718 A CN 201310011718A CN 103044331 A CN103044331 A CN 103044331A
- Authority
- CN
- China
- Prior art keywords
- methyl
- propylpyrazole
- amino
- ammonia
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 title abstract description 18
- PZMXDLWWQHYXGY-UHFFFAOYSA-N 4-amino-1-methyl-3-propylpyrazole-5-carboxamide Chemical compound CCCC1=NN(C)C(C(N)=O)=C1N PZMXDLWWQHYXGY-UHFFFAOYSA-N 0.000 title abstract description 11
- 229960003310 sildenafil Drugs 0.000 title abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 7
- ZPSRHLWRTVNGSM-UHFFFAOYSA-N ethyl 2-methyl-5-propylpyrazole-3-carboxylate Chemical compound CCCC=1C=C(C(=O)OCC)N(C)N=1 ZPSRHLWRTVNGSM-UHFFFAOYSA-N 0.000 claims abstract description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 20
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 14
- 229910021529 ammonia Inorganic materials 0.000 claims description 10
- PIFJFPDMEZBJSM-UHFFFAOYSA-N ethyl 4-bromo-2-methyl-5-propylpyrazole-3-carboxylate Chemical compound CCCC1=NN(C)C(C(=O)OCC)=C1Br PIFJFPDMEZBJSM-UHFFFAOYSA-N 0.000 claims description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Inorganic materials 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 5
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 claims 1
- 229960001701 chloroform Drugs 0.000 claims 1
- 235000015320 potassium carbonate Nutrition 0.000 claims 1
- 235000017550 sodium carbonate Nutrition 0.000 claims 1
- 238000009776 industrial production Methods 0.000 abstract description 4
- 238000005576 amination reaction Methods 0.000 abstract 1
- 230000031709 bromination Effects 0.000 abstract 1
- 238000005893 bromination reaction Methods 0.000 abstract 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 7
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000003226 pyrazolyl group Chemical group 0.000 description 4
- -1 4-bromo-3-isobutyl-1-methyl-1H-pyrazole Azole-5-carboxylic acid Chemical compound 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000005915 ammonolysis reaction Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 150000003217 pyrazoles Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- GFORSNBMYCLGIE-UHFFFAOYSA-N 1-methyl-4-nitro-3-propyl-1h-pyrazole-5-carboxylic acid Chemical compound CCCC1=NN(C)C(C(O)=O)=C1[N+]([O-])=O GFORSNBMYCLGIE-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- XDZMPRGFOOFSBL-UHFFFAOYSA-N 2-ethoxybenzoic acid Chemical compound CCOC1=CC=CC=C1C(O)=O XDZMPRGFOOFSBL-UHFFFAOYSA-N 0.000 description 1
- MDKAAWDKKBFSTK-UHFFFAOYSA-N 2-ethoxybenzoyl chloride Chemical compound CCOC1=CC=CC=C1C(Cl)=O MDKAAWDKKBFSTK-UHFFFAOYSA-N 0.000 description 1
- BMLPAJIEDKJHSB-UHFFFAOYSA-N 2-methyl-4-nitro-5-propylpyrazole-3-carboxamide Chemical compound CCCC1=NN(C)C(C(N)=O)=C1[N+]([O-])=O BMLPAJIEDKJHSB-UHFFFAOYSA-N 0.000 description 1
- FNZPEHCXMGHUNY-UHFFFAOYSA-N 2-methyl-5-(2-methylpropyl)pyrazole-3-carboxylic acid Chemical compound CC(C)CC=1C=C(C(O)=O)N(C)N=1 FNZPEHCXMGHUNY-UHFFFAOYSA-N 0.000 description 1
- KOABFSONXOOIIH-UHFFFAOYSA-N 2-methyl-5-propylpyrazole-3-carboxylic acid Chemical compound CCCC=1C=C(C(O)=O)N(C)N=1 KOABFSONXOOIIH-UHFFFAOYSA-N 0.000 description 1
- CRCIQSNGKBOGRX-UHFFFAOYSA-N 3-(1,1,2,2,3,3,3-heptafluoropropyl)-1-methylpyrazole Chemical compound CN1C=CC(C(F)(F)C(F)(F)C(F)(F)F)=N1 CRCIQSNGKBOGRX-UHFFFAOYSA-N 0.000 description 1
- WVGCPEDBFHEHEZ-UHFFFAOYSA-N 4-bromo-1h-pyrazole Chemical class BrC=1C=NNC=1 WVGCPEDBFHEHEZ-UHFFFAOYSA-N 0.000 description 1
- KMTFOQPBLCPPTP-UHFFFAOYSA-N 4-bromo-2-methyl-5-propylpyrazole-3-carboxylic acid Chemical compound CCCC1=NN(C)C(C(O)=O)=C1Br KMTFOQPBLCPPTP-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- ZXVOCOLRQJZVBW-UHFFFAOYSA-N azane;ethanol Chemical class N.CCO ZXVOCOLRQJZVBW-UHFFFAOYSA-N 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000005957 chlorosulfonylation reaction Methods 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- KCQWFZQMMAVRHG-UHFFFAOYSA-N ethyl 2-methyl-4-nitro-5-propylpyrazole-3-carboxylate Chemical compound CCCC1=NN(C)C(C(=O)OCC)=C1[N+]([O-])=O KCQWFZQMMAVRHG-UHFFFAOYSA-N 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 150000004395 organic heterocyclic compounds Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical group OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 229940094720 viagra Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了西地那非中间体4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺的新的制备方法。该方法以1-甲基-3-正丙基吡唑-5-甲酸乙酯为原料,经过溴代和氨化来制备4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺。本发明提供的新方法更加安全、高效和环保,更适合工业化生产。The invention discloses a new preparation method of sildenafil intermediate 4-amino-1-methyl-3-n-propylpyrazole-5-carboxamide. The method uses ethyl 1-methyl-3-n-propylpyrazole-5-carboxylate as a raw material to prepare 4-amino-1-methyl-3-n-propylpyrazole-5 through bromination and amination - Formamide. The new method provided by the invention is safer, more efficient and more environmentally friendly, and is more suitable for industrial production.
Description
技术领域technical field
本发明涉及西地那非中间体4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺的新的制备方法,属于医药中间体合成技术领域。The invention relates to a new preparation method of sildenafil intermediate 4-amino-1-methyl-3-n-propylpyrazole-5-carboxamide, belonging to the technical field of pharmaceutical intermediate synthesis.
背景技术Background technique
西地那非(Sildenafil),化学名为1-甲基-3-正丙基-5-[2-乙氧基-5-(4-甲基哌嗪-1-磺酰基)苯基]-1,6-二氢-7H-吡唑并[4,2-d]嘧啶-7-酮,临床上使用其枸橼酸盐,商品名为万艾可(Viagra),由辉瑞公司研发,用于治疗男性勃起功能障碍。西地那非的化学结构如下所示:Sildenafil, the chemical name is 1-methyl-3-n-propyl-5-[2-ethoxy-5-(4-methylpiperazine-1-sulfonyl)phenyl]- 1,6-dihydro-7H-pyrazolo[4,2-d]pyrimidin-7-one, its citrate salt is used clinically, the trade name is Viagra, developed by Pfizer, for the treatment of Erectile dysfunction in men. The chemical structure of sildenafil is shown below:
西地那非最主要的合成路线是以4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺(式I)和2-乙氧基苯甲酸或2-乙氧基苯甲酰氯为起始原料,经缩合反应、嘧啶酮环合反应、氯磺酰化和与甲基哌嗪缩合得到西地那非。该路线原料易得,而且反应易操作,收率高,适合工业化生产。反应式如下所示:The main synthetic route of sildenafil is based on 4-amino-1-methyl-3-n-propylpyrazole-5-carboxamide (formula I) and 2-ethoxybenzoic acid or 2-ethoxy Benzoyl chloride is used as the starting material, and sildenafil is obtained through condensation reaction, pyrimidinone ring closure reaction, chlorosulfonylation and condensation with methylpiperazine. The raw material of this route is easy to obtain, and the reaction is easy to operate, the yield is high, and it is suitable for industrial production. The reaction formula is as follows:
如上所述,式I所示的4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺是合成西地那非的关键中间体。文献报道的该中间体的合成路线是以2-戊酮为原料,在与草酸二乙酯缩合后,与水合肼环合得到吡唑环,甲基化后再水解后用混酸硝化得到4-硝基-1-甲基-3-正丙基吡唑-5-羧酸;再使用氯化亚砜氯化,得到酰氯后氨解得酰胺,最后还原硝基得到4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺。反应式如下所示:As mentioned above, 4-amino-1-methyl-3-n-propylpyrazole-5-carboxamide shown in formula I is a key intermediate for the synthesis of sildenafil. The synthetic route of this intermediate reported in the literature is to use 2-pentanone as a raw material. After condensation with diethyl oxalate, it is cyclized with hydrazine hydrate to obtain a pyrazole ring. After methylation, it is hydrolyzed and then nitrated with mixed acid to obtain 4-pentanone. Nitro-1-methyl-3-n-propylpyrazole-5-carboxylic acid; then use thionyl chloride to chlorinate to obtain acid chloride, then ammonolysis to obtain amide, and finally reduce nitro to obtain 4-amino-1-methyl Base-3-n-propylpyrazole-5-carboxamide. The reaction formula is as follows:
该合成路线中,共八步反应,并采用了混酸硝化吡唑环反应。该反应安全系数较低,极易引起爆炸,工业化时需要小心操作,并需要对反应进行严密监控,不利于大规模工业生产。此外,该路线采用氯化亚砜来制备酰氯,进而氨解得到酰胺。而氯化亚砜对设备的腐蚀很严重,并产生大量的酸水,给环保造成很大的压力。In this synthetic route, there are eight reactions in total, and the mixed acid nitration pyrazole ring reaction is adopted. The safety factor of this reaction is low, and it is very easy to cause an explosion. It needs careful operation and close monitoring of the reaction during industrialization, which is not conducive to large-scale industrial production. In addition, this route uses thionyl chloride to prepare acid chlorides, and then ammonolysis to obtain amides. However, thionyl chloride is very corrosive to equipment and produces a large amount of acid water, which puts a lot of pressure on environmental protection.
发明内容Contents of the invention
本发明的目的在于提供一种制备4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺的新方法,旨在克服上述制备方法中的缺点。新方法更加安全、高效和环保。The object of the present invention is to provide a new method for preparing 4-amino-1-methyl-3-n-propylpyrazole-5-carboxamide, aiming to overcome the shortcomings in the above-mentioned preparation method. The new method is safer, more efficient and environmentally friendly.
吡唑环的芳香性比较明显,可发生卤代、硝化、磺化等取代反应。陈敏为、甘礼骓主编的《有机杂环化合物》在介绍了吡唑的性质时提到,在醋酸钠水溶液中,吡唑与溴素反应,可得到4-溴吡唑(1990年,第一版,p151)。The aromaticity of the pyrazole ring is relatively obvious, and substitution reactions such as halogenation, nitration, and sulfonation can occur. "Organic Heterocyclic Compounds" edited by Chen Minwei and Gan Lizhao mentioned when introducing the properties of pyrazoles that in aqueous sodium acetate solution, pyrazoles react with bromine to obtain 4-bromopyrazoles (1990, First Edition, p151).
屠美玲等报道了3-异丁基-1-甲基-1H-吡唑-5-甲酸在氯仿溶液中与溴反应得到4-溴-3-异丁基-1-甲基-1H-吡唑-5-甲酸(浙江大学学报理学版,2008,35,641~643.)。Tu Meiling and others reported that 3-isobutyl-1-methyl-1H-pyrazole-5-carboxylic acid reacted with bromine in chloroform solution to obtain 4-bromo-3-isobutyl-1-methyl-1H-pyrazole Azole-5-carboxylic acid (Journal of Zhejiang University Science Edition, 2008, 35, 641~643.).
拜耳公司申请的中国专利报道了1-甲基-3-七氟丙基-1H-吡唑在水中与溴素反应得到4-溴-1-甲基-3-七氟丙基-1H-吡唑,收率78%(CN200980143450.3)。The Chinese patent applied by Bayer reported that 1-methyl-3-heptafluoropropyl-1H-pyrazole reacted with bromine in water to obtain 4-bromo-1-methyl-3-heptafluoropropyl-1H-pyrazole azole, yield 78% (CN200980143450.3).
Khan等报道了在二氯甲烷溶液中和在碳酸钾的存在下,1-甲基-3-正丙基-1H-吡唑-5-羧酸与溴素反应得到4-溴-1-甲基-3-正丙基-1H-吡唑-5-羧酸,收率88%(Molecular Diversity,2005,9,15~26.)。Khan et al. reported the reaction of 1-methyl-3-n-propyl-1H-pyrazole-5-carboxylic acid with bromine in the presence of potassium carbonate in methylene chloride to give 4-bromo-1-methyl -3-n-propyl-1H-pyrazole-5-carboxylic acid, the yield was 88% (Molecular Diversity, 2005, 9, 15-26.).
此外,吡唑环上的5-甲酸乙酯可以被氨水直接氨解为5-甲酰胺。宫平等报道了4-硝基-1-甲基-3-正丙基吡唑-5-甲酸乙酯与浓氨水反应得到4-硝基-1-甲基-3-正丙基吡唑-5-甲酰胺,收率84.4%(沈阳药科大学学报,2002,19,173~175.)。In addition, ethyl 5-carboxylate on the pyrazole ring can be directly ammonolyzed to 5-carboxamide by ammonia water. Gong et al reported the reaction of ethyl 4-nitro-1-methyl-3-n-propylpyrazole-5-carboxylate with concentrated ammonia to obtain 4-nitro-1-methyl-3-n-propylpyrazole- 5-Formamide, yield 84.4% (Journal of Shenyang Pharmaceutical University, 2002, 19, 173-175.).
在以上方法学的启发下,本发明设计并实施了以下合成4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺的新方法:以1-甲基-3-正丙基吡唑-5-甲酸乙酯(式II)为起始原料,在有机溶剂中并在一定的温度下,与溴素反应,得到4-溴-1-甲基-3-正丙基吡唑-5-甲酸乙酯(式III);4-溴-1-甲基-3-正丙基吡唑-5-甲酸乙酯与氨水或氨的醇溶液,在碱的存在下,并在一定的温度和压力下反应,得到4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺(式I)。反应式如下所示:Inspired by the above methodology, the present invention has designed and implemented the following new method for the synthesis of 4-amino-1-methyl-3-n-propylpyrazole-5-carboxamide: with 1-methyl-3-n- Propylpyrazole-5-ethyl carboxylate (formula II) is the starting material, in an organic solvent and at a certain temperature, reacts with bromine to obtain 4-bromo-1-methyl-3-n-propyl Ethyl pyrazole-5-carboxylate (formula III); ethyl 4-bromo-1-methyl-3-n-propylpyrazole-5-carboxylate and ammonia water or an alcoholic solution of ammonia, in the presence of a base, and React under certain temperature and pressure to obtain 4-amino-1-methyl-3-n-propylpyrazole-5-carboxamide (Formula I). The reaction formula is as follows:
具体来说,本发明提供的制备方法包括下列内容:Specifically, the preparation method provided by the invention includes the following contents:
以1-甲基-3-正丙基吡唑-5-甲酸乙酯(II)为起始原料,在有机溶剂中并在一定的温度下,与溴素反应,得到4-溴-1-甲基-3-正丙基吡唑-5-甲酸乙酯(III)。其中有机溶剂选自二氯甲烷、三氯甲烷、四氯化碳、二硫化碳、1,2-二氯乙烷、1,2-二溴乙烷、水中的一种或几种混合物;反应温度在-10℃至溶剂的回流温度,优选10~50℃。With 1-methyl-3-n-propylpyrazole-5-ethyl carboxylate (II) as the starting material, react with bromine in an organic solvent and at a certain temperature to obtain 4-bromo-1- Ethyl methyl-3-n-propylpyrazole-5-carboxylate (III). Wherein the organic solvent is selected from one or more mixtures of dichloromethane, chloroform, carbon tetrachloride, carbon disulfide, 1,2-dichloroethane, 1,2-dibromoethane, water; the reaction temperature is at -10°C to the reflux temperature of the solvent, preferably 10 to 50°C.
4-溴-1-甲基-3-正丙基吡唑-5-甲酸乙酯(III)与氨水或氨的醇溶液,在碱的存在下,并在一定的温度和压力下反应,得到4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺(I)。其中氨的醇溶液为氨的甲醇溶液或氨的乙醇溶液;碱选自碳酸钠、碳酸钾、碳酸氢钠、三乙胺、吡啶、4-二甲胺基吡啶、DBU中的一种或几种混合物;反应温度为10~150℃,优选40~100℃。4-bromo-1-methyl-3-n-propylpyrazole-5-ethyl carboxylate (III) and ammonia water or ammonia alcohol solution, in the presence of a base, and react at a certain temperature and pressure to obtain 4-Amino-1-methyl-3-n-propylpyrazole-5-carboxamide (I). Wherein the alcohol solution of ammonia is methanol solution of ammonia or ethanol solution of ammonia; alkali is selected from one or more of sodium carbonate, potassium carbonate, sodium bicarbonate, triethylamine, pyridine, 4-dimethylaminopyridine, DBU A mixture; the reaction temperature is 10-150°C, preferably 40-100°C.
本发明提供的方法不仅革除了安全系数低的硝化反应,避免使用强腐蚀、强刺激性的氯化亚砜,且缩短了2步反应,使得操作工艺更易控制,且总收率提高了20%以上。总之,本发明提供的新方法更加安全、高效和环保,更适合工业化生产。The method provided by the invention not only eliminates the nitrification reaction with a low safety factor, avoids the use of strong corrosion and strong irritating sulfur oxychloride, but also shortens the two-step reaction, makes the operation process easier to control, and increases the total yield by 20%. above. In a word, the new method provided by the invention is safer, more efficient and environmentally friendly, and more suitable for industrial production.
具体实施方式Detailed ways
以下典型实施例用来举例说明本发明,在本领域内的技术人员对本发明所做的简单替换或改进等均属于本发明所保护的技术方案之内。The following typical embodiments are used to illustrate the present invention. Simple replacements or improvements made by those skilled in the art are within the technical solutions protected by the present invention.
实施例1:4-溴-1-甲基-3-正丙基吡唑-5-甲酸乙酯的制备(III)Example 1: Preparation of ethyl 4-bromo-1-methyl-3-n-propylpyrazole-5-carboxylate (III)
在装有机械搅拌的5000ml的三口瓶中加入2500ml二氯甲烷和196.1g的1-甲基-3-正丙基吡唑-5-甲酸乙酯(1.0mol),控制反应控温10℃以下,避光条件下缓慢滴加液溴239.8g(1.5mol),约1h滴加完毕,升温至室温反应,TLC跟踪,直至原料点消失。随后缓慢滴加入1000ml的15%碳酸钠溶液,滴加完毕后搅拌1h,静置分层,弃去水层,有机相用无水硫酸钠干燥,过滤,蒸去溶剂,残余物用乙酸乙酯重结晶得到产品261.4g,收率95.4%。Add 2500ml of dichloromethane and 196.1g of ethyl 1-methyl-3-n-propylpyrazole-5-carboxylate (1.0mol) into a 5000ml three-necked flask equipped with mechanical stirring, and control the reaction temperature below 10°C 239.8g (1.5mol) of liquid bromine was slowly added dropwise under dark conditions, and the dropwise addition was completed in about 1 hour, and the temperature was raised to room temperature for reaction, followed by TLC until the raw material point disappeared. Then slowly add 1000ml of 15% sodium carbonate solution dropwise, stir for 1h after the dropwise addition, let the layers stand, discard the water layer, dry the organic phase with anhydrous sodium sulfate, filter, evaporate the solvent, and wash the residue with ethyl acetate 261.4 g of the product was obtained by recrystallization, with a yield of 95.4%.
实施例2:4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺的制备(I)Embodiment 2: the preparation of 4-amino-1-methyl-3-n-propylpyrazole-5-carboxamide (I)
在3000ml的高压釜中加入200g的4-溴-1-甲基-3-正丙基吡唑-5-甲酸乙酯(0.73mol)和1800ml的浓氨水,密闭,开启搅拌,升温至60℃反应,TLC跟踪,直至原料点消失。降温至室温后,减压浓缩至干,残余物用乙酸乙酯重结晶得产品140.8g,收率91%。Add 200g of ethyl 4-bromo-1-methyl-3-n-propylpyrazole-5-carboxylate (0.73mol) and 1800ml of concentrated ammonia water into a 3000ml autoclave, close it, start stirring, and heat up to 60°C The reaction was followed by TLC until the raw material spots disappeared. After cooling down to room temperature, it was concentrated to dryness under reduced pressure, and the residue was recrystallized from ethyl acetate to obtain 140.8 g of the product, with a yield of 91%.
实施例3:4-氨基-1-甲基-3-正丙基吡唑-5-甲酰胺的制备(I)Embodiment 3: the preparation of 4-amino-1-methyl-3-n-propylpyrazole-5-carboxamide (I)
在3000ml的高压釜中加入200g的4-溴-1-甲基-3-正丙基吡唑-5-甲酸乙酯(0.73mol)、1800ml的饱和氨的乙醇溶液和57.7g吡啶(0.73mol),密闭,开启搅拌,升温至80℃反应,TLC跟踪,直至原料点消失。降温至室温后,减压浓缩蒸除溶剂,残余物用1500ml二氯甲烷溶解,分别用1N的盐酸(600ml×3)和水(500ml×2)洗涤,残余物用乙酸乙酯重结晶得产品135.6g,收率87.6%。In a 3000ml autoclave, add 200g of 4-bromo-1-methyl-3-n-propylpyrazole-5-ethyl carboxylate (0.73mol), 1800ml of saturated ammonia ethanol solution and 57.7g of pyridine (0.73mol ), airtight, start stirring, heat up to 80°C for reaction, TLC tracking, until the raw material point disappears. After cooling down to room temperature, concentrate under reduced pressure to remove the solvent, dissolve the residue with 1500ml of dichloromethane, wash with 1N hydrochloric acid (600ml×3) and water (500ml×2) respectively, and recrystallize the residue with ethyl acetate to obtain the product 135.6g, yield 87.6%.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310011718.6A CN103044331B (en) | 2013-01-14 | 2013-01-14 | Prepare the new method of the formamide of 3 n-propyl pyrazoles of silaenafil intermediate 4 amino, 1 methyl 5 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310011718.6A CN103044331B (en) | 2013-01-14 | 2013-01-14 | Prepare the new method of the formamide of 3 n-propyl pyrazoles of silaenafil intermediate 4 amino, 1 methyl 5 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103044331A true CN103044331A (en) | 2013-04-17 |
CN103044331B CN103044331B (en) | 2017-09-15 |
Family
ID=48057216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310011718.6A Active CN103044331B (en) | 2013-01-14 | 2013-01-14 | Prepare the new method of the formamide of 3 n-propyl pyrazoles of silaenafil intermediate 4 amino, 1 methyl 5 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103044331B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0253776A (en) * | 1988-08-17 | 1990-02-22 | Mitsubishi Kasei Corp | 4-halogeno-5-pyrazolecarboxylic acid derivative |
US6200980B1 (en) * | 1995-06-07 | 2001-03-13 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl purinone derivatives |
WO2002016364A1 (en) * | 2000-08-23 | 2002-02-28 | Lg Life Sciences Ltd. | Polyethoxylated pyrazolo pyrimidinone derivatives, process for preparation thereof and pharmaceutical compositions comprising the same for the treatment of impotence |
CN1358722A (en) * | 2001-08-21 | 2002-07-17 | 常州市天普生物化学制药厂 | Process for preparing citrat |
CN102267986A (en) * | 2011-09-01 | 2011-12-07 | 中国农业大学 | Pyrazole bisamide compounds as well as synthesis method and application thereof |
-
2013
- 2013-01-14 CN CN201310011718.6A patent/CN103044331B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0253776A (en) * | 1988-08-17 | 1990-02-22 | Mitsubishi Kasei Corp | 4-halogeno-5-pyrazolecarboxylic acid derivative |
US6200980B1 (en) * | 1995-06-07 | 2001-03-13 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl purinone derivatives |
WO2002016364A1 (en) * | 2000-08-23 | 2002-02-28 | Lg Life Sciences Ltd. | Polyethoxylated pyrazolo pyrimidinone derivatives, process for preparation thereof and pharmaceutical compositions comprising the same for the treatment of impotence |
CN1358722A (en) * | 2001-08-21 | 2002-07-17 | 常州市天普生物化学制药厂 | Process for preparing citrat |
CN102267986A (en) * | 2011-09-01 | 2011-12-07 | 中国农业大学 | Pyrazole bisamide compounds as well as synthesis method and application thereof |
Non-Patent Citations (2)
Title |
---|
沈之芹: "《合成化学》", 《3-正丙基-4-氨基-5-酰胺基-1-甲基吡唑的合成》 * |
秦绍清: "《4-氨基-1-甲基-3-丙基吡唑-5-甲酰胺的合成新路线》", 《精细与专用化学品》 * |
Also Published As
Publication number | Publication date |
---|---|
CN103044331B (en) | 2017-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2881373T3 (en) | An improved procedure for the preparation of apixaban and its intermediates | |
JP2015500335A5 (en) | ||
EP2128139A1 (en) | Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarbonitrile derivative and method for producing the same | |
CN102030716B (en) | Method for preparing gefitinib | |
CN101020658B (en) | Synthesis process of main cyclic quinoline compound | |
CN103709110B (en) | A kind of preparation method of erlotinid hydrochloride key intermediate | |
CN103396366B (en) | The production method of 5-Amino 3 cyano-1-(2,6-dichlor-4-trifluoromethyl phenyl) pyrazoles | |
ZA200609242B (en) | Improved process for the preparation of biologically active tetrahydrobenzthiazole derivative | |
CN106699570A (en) | Synthesis method for (2-chloro-5-iodophenyl)(4-fluorophenyl)ketone | |
CN105859615A (en) | Novel preparation method and novel intermediate of dequalinium chloride | |
CN107312003A (en) | A kind of synthetic method for preparing the chlorine guanine of 2 amino of high-purity 6 | |
CN103044331B (en) | Prepare the new method of the formamide of 3 n-propyl pyrazoles of silaenafil intermediate 4 amino, 1 methyl 5 | |
CN103242272A (en) | Method for preparing benzbromarone | |
CN108623602B (en) | A method of preparing and purifying ibrutinib | |
BR112014019961B1 (en) | telescopic (single-row sequential) process for synthesizing 5-amino-4-nitrous-1-alkyl-1h-pyrazole salt and for producing a 4,5-diamino-1-alkylpyrazole salt | |
CN102731328B (en) | Preparation method of bupropion hydrochloride | |
CN106243009B (en) | A kind of preparation method of the bromo- N-phenylmaleimides of 3- n-butylamine-baseds -4- | |
CN104447758A (en) | Synthesis process of pyrazolo[3,4-d]pyrimidine compounds | |
CN101337946A (en) | A kind of preparation method of demethylaminothiaxamic acid ethyl ester | |
CN100462357C (en) | The preparation method of 8-bromo-5,6-difluoro-2-methylquinoline | |
CN115385903A (en) | A kind of preparation method of cyano-substituted benzoxazin-4-one derivative | |
CN104876872B (en) | A kind of method for preparing the methylol indazole of 1 tert-butoxycarbonyl 3 and application | |
CN106518850A (en) | Chemical synthesis method of Pimobendan | |
CN105968054B (en) | Preparation of pimobendan key intermediate | |
CN100376551C (en) | A kind of synthetic method of semicarbazone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170921 Address after: 213200, No. 6, Chang Dong Dong Road, Jintan District, Jiangsu, Changzhou Patentee after: Changzhou Yabang Pharmaceutical Co., Ltd. Address before: 213163 No. 105 Renmin West Road, Wujin District, Jiangsu, Changzhou Co-patentee before: Changzhou Yabang Pharmaceutical Co., Ltd. Patentee before: Changzhou Yabang Pharmaceutical & Chemical Co., Ltd. Co-patentee before: Yabang Pharmaceutical Co., Ltd. |
|
TR01 | Transfer of patent right |